Annual Total Assets
$10.66 M
-$479.00 K-4.30%
December 31, 2023
Summary
- As of February 7, 2025, RSLS annual total assets is $10.66 million, with the most recent change of -$479.00 thousand (-4.30%) on December 31, 2023.
- During the last 3 years, RSLS annual total assets has fallen by -$26.40 million (-71.23%).
- RSLS annual total assets is now -87.98% below its all-time high of $88.70 million, reached on December 31, 2017.
Performance
RSLS Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$5.62 M
-$778.00 K-12.17%
September 30, 2024
Summary
- As of February 7, 2025, RSLS quarterly total assets is $5.62 million, with the most recent change of -$778.00 thousand (-12.17%) on September 30, 2024.
- Over the past year, RSLS quarterly total assets has dropped by -$2.21 million (-28.26%).
- RSLS quarterly total assets is now -95.32% below its all-time high of $120.00 million, reached on June 30, 2021.
Performance
RSLS Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
RSLS Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.3% | -28.3% |
| 3 y3 years | -71.2% | -93.8% |
| 5 y5 years | -77.0% | -84.7% |
RSLS Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.7% | at low | -89.3% | at low |
| 5 y | 5-year | -79.7% | at low | -95.3% | at low |
| alltime | all time | -88.0% | +1387.2% | -95.3% | at low |
ReShape Lifesciences Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.62 M(-12.2%) |
| Jun 2024 | - | $6.39 M(-22.3%) |
| Mar 2024 | - | $8.23 M(-22.8%) |
| Dec 2023 | $10.66 M(-4.3%) | $10.66 M(+36.2%) |
| Sep 2023 | - | $7.83 M(-34.0%) |
| Jun 2023 | - | $11.85 M(-27.5%) |
| Mar 2023 | - | $16.35 M(+46.8%) |
| Dec 2022 | $11.14 M(-78.8%) | $11.14 M(-60.8%) |
| Sep 2022 | - | $28.46 M(-32.1%) |
| Jun 2022 | - | $41.92 M(-11.3%) |
| Mar 2022 | - | $47.27 M(-10.0%) |
| Dec 2021 | $52.53 M(+41.7%) | $52.53 M(-42.1%) |
| Sep 2021 | - | $90.70 M(-24.4%) |
| Jun 2021 | - | $120.00 M(+233.2%) |
| Mar 2021 | - | $36.02 M(-2.8%) |
| Dec 2020 | $37.06 M(-6.5%) | $37.06 M(+1.3%) |
| Sep 2020 | - | $36.59 M(-1.5%) |
| Jun 2020 | - | $37.14 M(-1.1%) |
| Mar 2020 | - | $37.56 M(-5.3%) |
| Dec 2019 | $39.66 M(-14.3%) | $39.66 M(-10.2%) |
| Sep 2019 | - | $44.18 M(+1.1%) |
| Jun 2019 | - | $43.69 M(-7.9%) |
| Mar 2019 | - | $47.42 M(+2.5%) |
| Dec 2018 | $46.27 M(-47.8%) | $46.27 M(-1.7%) |
| Sep 2018 | - | $47.05 M(-6.8%) |
| Jun 2018 | - | $50.51 M(-35.7%) |
| Mar 2018 | - | $78.57 M(-11.4%) |
| Dec 2017 | $88.70 M(+1159.9%) | $88.70 M(+60.7%) |
| Sep 2017 | - | $55.18 M(+29.8%) |
| Jun 2017 | - | $42.52 M(+95.9%) |
| Mar 2017 | - | $21.71 M(+208.3%) |
| Dec 2016 | $7.04 M(-39.2%) | $7.04 M(-33.4%) |
| Sep 2016 | - | $10.58 M(-29.4%) |
| Jun 2016 | - | $14.99 M(+0.9%) |
| Mar 2016 | - | $14.86 M(+28.2%) |
| Dec 2015 | $11.59 M | $11.59 M(-22.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $15.01 M(+90.4%) |
| Jun 2015 | - | $7.88 M(-45.0%) |
| Mar 2015 | - | $14.34 M(-0.3%) |
| Dec 2014 | $14.39 M(-45.5%) | $14.39 M(-23.8%) |
| Sep 2014 | - | $18.89 M(-22.6%) |
| Jun 2014 | - | $24.41 M(-11.4%) |
| Mar 2014 | - | $27.55 M(+4.4%) |
| Dec 2013 | $26.39 M(+1.1%) | $26.39 M(+7.0%) |
| Sep 2013 | - | $24.66 M(-8.2%) |
| Jun 2013 | - | $26.88 M(-19.1%) |
| Mar 2013 | - | $33.22 M(+27.3%) |
| Dec 2012 | $26.10 M(-19.7%) | $26.10 M(-15.1%) |
| Sep 2012 | - | $30.72 M(+0.7%) |
| Jun 2012 | - | $30.52 M(+24.3%) |
| Mar 2012 | - | $24.55 M(-24.4%) |
| Dec 2011 | $32.49 M(-16.0%) | $32.49 M(-12.2%) |
| Sep 2011 | - | $37.00 M(+27.3%) |
| Jun 2011 | - | $29.07 M(-13.7%) |
| Mar 2011 | - | $33.68 M(-12.9%) |
| Dec 2010 | $38.69 M(+138.6%) | $38.69 M(+162.4%) |
| Sep 2010 | - | $14.74 M(+25.3%) |
| Jun 2010 | - | $11.77 M(-27.3%) |
| Mar 2010 | - | $16.18 M(-0.2%) |
| Dec 2009 | $16.21 M(-42.7%) | $16.21 M(-43.4%) |
| Sep 2009 | - | $28.64 M(-21.8%) |
| Jun 2009 | - | $36.62 M(-1.5%) |
| Mar 2009 | - | $37.18 M(+31.5%) |
| Dec 2008 | $28.28 M(-52.1%) | $28.28 M(-6.8%) |
| Sep 2008 | - | $30.33 M(-24.9%) |
| Jun 2008 | - | $40.39 M(-19.4%) |
| Mar 2008 | - | $50.09 M(-15.2%) |
| Dec 2007 | $59.05 M(+63.7%) | $59.05 M(+139.5%) |
| Sep 2007 | - | $24.66 M(-31.6%) |
| Dec 2006 | $36.06 M(+211.9%) | $36.06 M(+211.9%) |
| Dec 2005 | $11.56 M(+1512.4%) | $11.56 M |
| Dec 2003 | $717.00 K | - |
FAQ
- What is ReShape Lifesciences annual total assets?
- What is the all time high annual total assets for ReShape Lifesciences?
- What is ReShape Lifesciences annual total assets year-on-year change?
- What is ReShape Lifesciences quarterly total assets?
- What is the all time high quarterly total assets for ReShape Lifesciences?
- What is ReShape Lifesciences quarterly total assets year-on-year change?
What is ReShape Lifesciences annual total assets?
The current annual total assets of RSLS is $10.66 M
What is the all time high annual total assets for ReShape Lifesciences?
ReShape Lifesciences all-time high annual total assets is $88.70 M
What is ReShape Lifesciences annual total assets year-on-year change?
Over the past year, RSLS annual total assets has changed by -$479.00 K (-4.30%)
What is ReShape Lifesciences quarterly total assets?
The current quarterly total assets of RSLS is $5.62 M
What is the all time high quarterly total assets for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly total assets is $120.00 M
What is ReShape Lifesciences quarterly total assets year-on-year change?
Over the past year, RSLS quarterly total assets has changed by -$2.21 M (-28.26%)